These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy. Chen XS, Li WZ, Jiang C, Ye GY. Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911 [Abstract] [Full Text] [Related]
5. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS. Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [Abstract] [Full Text] [Related]
7. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients. Becx-Bleumink M. Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986 [Abstract] [Full Text] [Related]
18. New lesions after MDT in PB and MB leprosy: a report of 28 cases. Kar HK, Sharma P. Indian J Lepr; 2008 Sep; 80(3):247-55. PubMed ID: 19432355 [Abstract] [Full Text] [Related]